|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.9101 USD | -1.14% |
|
+1.09% | +3.53% |
| Mar. 15 | Fresh Tracks Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| 2023 | Fresh Tracks Therapeutics, Inc.(OTCPK:FRTX) dropped from S&P TMI Index | CI |
Fresh Tracks Therapeutics, Inc. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported revenue was USD 6.94 million compared to USD 0.404 million a year ago. Net loss was USD 21.1 million compared to USD 39.47 million a year ago.
Basic loss per share from continuing operations was USD 7.51 compared to USD 22.12 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +3.53% | 5.44M | |
| -2.31% | 103B | |
| +0.56% | 95.28B | |
| +1.69% | 22.15B | |
| -17.37% | 21.02B | |
| -9.30% | 18.15B | |
| -41.01% | 16.74B | |
| -14.85% | 16.05B | |
| +3.21% | 13.68B | |
| +33.54% | 12.17B |
FRESH TRACKS THERAPEUTICS, INC. 
